4//SEC Filing
CHRISTOPHER RICHARD 4
Accession 0001348362-25-000012
CIK 0001348362other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 11:14 AM ET
Size
8.1 KB
Accession
0001348362-25-000012
Insider Transaction Report
Form 4
CHRISTOPHER RICHARD
DirectorChief Executive Officer
Transactions
- Purchase
common shares
2025-07-29$0.91/sh+15,000$13,641→ 65,000 total
Holdings
- 200,000
Stock Options
Exercise: $3.92From: 2025-02-28Exp: 2029-08-31→ Common Shares (200,000 underlying) - 50,000
common shares
- 350,000
Stock Options
Exercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (150,000 underlying)
Footnotes (1)
- [F1]50,000 options were exercisable on Feb. 28, 2025, an additional 6,818 options are exercisable every month thereafter until November 30, 2026 whereby the balance of 6,822 options will be exercisable December 31, 2026
Documents
Issuer
Lexaria Bioscience Corp.
CIK 0001348362
Entity typeother
Related Parties
1- filerCIK 0001271244
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 11:14 AM ET
- Size
- 8.1 KB